Venrock Healthcare Capital Partners III, L.P.

13F Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 678K shares
Security Ownership: 1.5%

Venrock Healthcare Capital Partners III, L.P. ownership in 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT)

2025-05-15 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 678K shares of 4D Molecular Therapeutics, Inc. Common Stock, par value $0.0001 per share (FDMT). This represents 1.5% percent ownership of the company. In their previous filing dated 2025-02-14, Venrock Healthcare Capital Partners III, L.P. had reported owning 2.95M shares, indicating a decrease of -77% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
Venrock Healthcare Capital Partners III, L.P.	1.5%	-81.7%	$1.8M	678K	-2,274,771	-77%	$2.65	13G/A	3/31/2025	15 May 2025 17:44:19
Venrock Healthcare Capital Partners III, L.P.	6.4%		$7.82M	2.95M			$2.65	13G/A	12/31/2024	14 Feb 2025 18:09:36